SCHEMBL25548149

SCHEMBL25548149

c1ccc(-c2cc(-c3cccc(-c4ccc5ccccc5c4)c3)nc(-c3ccc4ccc5ccc6nn(-c7ccccc7)nc6c5c4c3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.41
CYP1B1 Q16678 1/20 0.41
ALOX5 P09917 1/20 0.38
MEN1 O00255 6/20 0.36
KMT2A Q03164 6/20 0.36
ALDH1A1 P00352 5/20 0.36
MAPT P10636 5/20 0.36
HPGD P15428 4/20 0.36
KDM4E B2RXH2 3/20 0.36
LMNA P02545 3/20 0.36
CYP1A2 P05177 1/20 0.34
GLA P06280 1/20 0.34
CTRC Q99895 1/20 0.34
PARP1 P09874 1/20 0.33
NTSR1 P30989 1/20 0.33
PTGES O14684 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
NPC1 O15118 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25548153 0.99 CYP1A1 (0.39) CYP1A1CYP1B1ALOX5MEN1KMT2A
SCHEMBL25548151 0.97 CYP1A1 (0.43) CYP1A1CYP1B1ALOX5MEN1KMT2A
SCHEMBL25548148 0.95 MEN1 (0.39) ALOX5MEN1KMT2AALDH1A1MAPT
SCHEMBL25548152 0.95 ALOX5 (0.41) CYP1A1CYP1B1ALOX5MEN1KMT2A
SCHEMBL25548145 0.94 ALOX5 (0.40) ALOX5MEN1KMT2AALDH1A1MAPT
SCHEMBL25548147 0.94 ALOX5 (0.38) ALOX5MEN1KMT2AALDH1A1MAPT
SCHEMBL25548142 0.93 ALOX5 (0.40) ALOX5MEN1KMT2AALDH1A1MAPT
SCHEMBL25548279 0.93 ALOX5 (0.40) ALOX5MEN1KMT2AALDH1A1MAPT
SCHEMBL25548608 0.92 ALOX5 (0.41) CYP1A1CYP1B1ALOX5MEN1KMT2A
SCHEMBL25548609 0.90 ALOX5 (0.40) CYP1A1CYP1B1ALOX5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167089-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-06-01 US disclosed
US-20230167089-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-06-01 US disclosed
US-20230157161-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-05-18 US disclosed
US-20230157161-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-05-18 US disclosed
US-20230134923-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-05-04 US disclosed
US-20230134923-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167089-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF PIEZO1, VCL, VDAC3 CYP1A1 1376/4885CYP1B1 1916/4885ALOX5 977/4885
US-20230134923-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF PIEZO1, VCL, VDAC3 CYP1A1 1376/4885CYP1B1 1916/4885ALOX5 977/4885
US-20230157161-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF PIEZO1, VCL, VDAC3 CYP1A1 1376/4885CYP1B1 1916/4885ALOX5 977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.